tirzepatide/cyano First Time Tirzepatide I know this question has

Viking Therapeutics is targeting this unmet medical need

indicate that most patients on GLP1 therapy can maintain their weight after stopping the medication

This difference may relate to the dual GIP/GLP-1 mechanism of tirzepatide versus the GLP-1-only action of semaglutide, though this is speculative

However, it does not predict medication response and should not replace medical evaluation of breastfeeding safety

A useful approach is to take a control biopsy from the contralateral side of the face.11 In general, biopsy of suspicious or changing pigmented lesions on the face is recommended.12 Excisional biopsy is the most accurate diagnostic method in LM, but because lesions are often large and located in cosmetically sensitive areas, punch biopsy is the most widely used procedure,13 despite the problem of sampling error.14 Based on observational studies by Stevens and Cocherell,15 deep incisional biopsy extending as far as the subcutaneous tissue with a punch of at least 5mm can minimize this source of error